Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081874
Status:
COMPLETED
Last Update Posted:
2023-10-13
First Post:
2004-04-23
Brief Title:
RAD001 in Relapsed or Refractory AML ALL CML in Blastic-Phase Agnogenic Myeloid Metaplasia CLL T-Cell Leukemia or Mantle Cell Lymphoma
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelofibrosis |
| Leukemia |
| Mantle Cell Lymphoma |
Keywords:
| Name | View |
|---|---|
| Afinitor | View |
| Leukemia | View |
| Mantle cell lymphoma | View |
| Myelofibrosis | View |
| Relapsed or Refractory Acute Myeloid Leukemia | View |
| Acute Lymphocytic Leukemia | View |
| Chronic Myeloid Leukemia in Blastic-Phase | View |
| Agnogenic Myeloid Metaplasia | View |
| Chronic Lymphocytic Leukemia | View |
| T-Cell Leukemia | View |
| RAD001 | View |
| Everolimus | View |